StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
51
This year
2
Publishing Date
2024 - 02 - 29
1
2024 - 02 - 09
1
2023 - 11 - 23
1
2023 - 11 - 10
1
2023 - 10 - 30
1
2023 - 10 - 04
1
2023 - 08 - 16
1
2023 - 08 - 08
1
2023 - 07 - 27
1
2023 - 03 - 16
1
2023 - 03 - 13
1
2023 - 02 - 27
1
2023 - 02 - 22
1
2023 - 02 - 08
1
2023 - 01 - 25
1
2023 - 01 - 11
1
2023 - 01 - 02
1
2022 - 12 - 26
1
2022 - 12 - 21
1
2022 - 12 - 15
1
2022 - 12 - 06
1
2022 - 10 - 25
1
2022 - 10 - 06
1
2022 - 08 - 25
1
2022 - 08 - 12
1
2022 - 07 - 29
2
2022 - 07 - 04
1
2022 - 06 - 14
1
2022 - 06 - 03
1
2022 - 06 - 01
1
2022 - 04 - 26
2
2022 - 03 - 21
1
2022 - 02 - 28
1
2022 - 02 - 14
1
2022 - 01 - 03
1
2021 - 12 - 13
1
2021 - 11 - 09
1
2021 - 11 - 02
1
2021 - 10 - 06
1
2021 - 09 - 07
1
2021 - 08 - 12
1
2021 - 07 - 22
1
2021 - 07 - 21
1
2021 - 05 - 26
1
2021 - 05 - 24
1
2021 - 03 - 25
1
2021 - 03 - 18
1
2021 - 01 - 06
1
2020 - 12 - 28
1
Sector
Commercial services
1
Communications
2
Finance
1
Health services
2
Health technology
51
Manufacturing
7
Professional, scientific, and technical services
1
Tags
Acquisition
9
Active
10
Antiviral
10
Application
24
Approval
31
Authorization
14
Breast
12
Cancer
66
Candidate
16
Children
18
Clinical-trials-phase-ii
9
Clinical-trials-phase-iii
15
Collaboration
21
Comirnaty®
10
Conference
18
Covid
58
Covid-19
41
Disease
28
Drug
54
Earnings
20
Ema
10
Emergency use authorization
10
Europe
13
Events
12
Expected
10
Fda
74
Fda-approvals
14
Financial
19
Global
56
Growth
29
Hiv
15
Hormone
10
License
19
Market
100
Merge
15
N/a
432
Order
15
People
24
Pharm-country
34
Pharmaceutical
17
Phase 2
12
Phase 3
21
Positive
45
Potential
11
Product-news
10
Regulatory
12
Report
49
Research
51
Respiratory
10
Results
62
Risk
16
Study
20
Therapeutics
40
Therapy
29
Topline
14
Treatment
74
Trial
47
Ulcerative colitis
12
Update
14
Vaccine
106
Entities
3m company
99
Abb ltd
165
Abbott laboratories
195
Abbvie inc.
81
Accenture plc
48
Acm research, inc.
59
Agilent technologies, inc.
79
Alphabet inc.
57
Apple inc.
89
Arrival
53
Astrazeneca plc
73
Baxter international inc.
47
Becton, dickinson and company
101
Bio-rad laboratories, inc.
93
Boston scientific corporation
66
Bristol-myers squibb company
80
Broadcom inc.
50
Celanese corporation
49
Cisco systems, inc.
155
Cummins inc.
48
Danaher corporation
128
Denso corp
55
Eastman chemical company
52
Eli lilly and company
148
Ericsson
118
Exxon mobil corporation
52
General electric company
112
Gilead sciences, inc.
54
Glaxosmithkline plc
88
Honeywell international inc.
214
Icon plc
46
Illumina, inc.
59
Infineon technologies ag
61
Intel corporation
136
International business machines corporation
83
Johnson & johnson
318
Koninklijke philips n.v.
120
Laboratory corporation of america holdings
49
Lam research corporation
55
Linde plc
47
Lockheed martin corporation
78
Medtronic plc
132
Microsoft corporation
225
Nec corp
65
Nokia corporation
46
Northrop grumman corporation
62
Novartis ag
129
Nvidia corporation
56
Oracle corporation
192
Orange
741
Panasonic corp
61
Perkinelmer, inc.
53
Pfizer, inc.
51
Qiagen n.v.
62
Raytheon technologies corporation
53
Sanofi
266
Sap se
181
Stryker corporation
72
Teva pharmaceutical industries ltd
59
Thermo fisher scientific inc
257
Symbols
ABBV
5
ABT
1
AERI
1
ALPMF
5
ALPMY
5
AMGN
2
ANIK
1
ARVN
1
AZN
7
AZNCF
6
BHC
1
BHVN
1
BMY
7
BNTX
3
CDTX
1
CRL
1
EBS
1
FNCTF
2
GILD
3
GLAXF
6
GSK
7
ICLR
1
INO
1
IONS
1
JNJ
11
LLY
7
MDT
1
MDXG
1
MS
1
NBIX
1
NUVA
1
NVAX
1
NVO
2
NVS
10
NVSEF
9
PFE
51
PYXS
1
REGN
1
RIGL
1
SCYX
1
SGEN
1
SNGX
1
SNY
12
SNYNF
12
SYNH
1
TAK
4
TDOC
1
TEVA
1
TEVJF
4
TMO
1
UCBJF
2
UCBJY
2
VRTX
1
VYGR
1
WST
1
Exchanges
Nasdaq
28
Nyse
51
Crawled Date
2024 - 02 - 29
1
2024 - 02 - 09
1
2023 - 11 - 23
1
2023 - 11 - 10
1
2023 - 10 - 30
1
2023 - 10 - 04
1
2023 - 08 - 16
1
2023 - 08 - 08
1
2023 - 07 - 27
1
2023 - 03 - 16
1
2023 - 03 - 13
1
2023 - 02 - 27
1
2023 - 02 - 22
1
2023 - 02 - 08
1
2023 - 01 - 25
1
2023 - 01 - 11
1
2023 - 01 - 02
1
2022 - 12 - 26
1
2022 - 12 - 21
1
2022 - 12 - 15
1
2022 - 12 - 06
1
2022 - 10 - 25
1
2022 - 10 - 06
1
2022 - 08 - 25
1
2022 - 08 - 12
1
2022 - 07 - 29
2
2022 - 07 - 04
1
2022 - 06 - 14
1
2022 - 06 - 03
1
2022 - 06 - 01
1
2022 - 04 - 26
2
2022 - 03 - 21
1
2022 - 02 - 28
1
2022 - 02 - 14
1
2022 - 01 - 03
1
2021 - 12 - 13
1
2021 - 11 - 09
1
2021 - 11 - 02
1
2021 - 10 - 06
1
2021 - 09 - 07
1
2021 - 08 - 12
1
2021 - 07 - 22
1
2021 - 07 - 21
1
2021 - 05 - 26
1
2021 - 05 - 24
1
2021 - 03 - 25
1
2021 - 03 - 18
1
2021 - 01 - 06
1
2020 - 12 - 28
1
Crawled Time
01:00
1
06:00
1
07:00
1
09:00
3
10:00
3
11:00
4
12:00
5
12:15
1
12:20
3
12:30
2
13:00
5
13:20
2
14:00
4
14:20
1
15:00
3
15:20
2
15:30
1
16:00
2
17:00
1
18:00
1
19:00
1
21:00
1
22:00
1
23:00
2
Source
www.biospace.com
23
www.prnewswire.com
28
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Research
entities :
Pfizer, inc.
save search
Pfizer Announces Positive Top-Line Data for Full Season Two Efficacy of ABRYSVO® for RSV in Older Adults
Published:
2024-02-29
(Crawled : 16:00)
- biospace.com/
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-2.88%
|
O:
0.11%
H:
0.44%
C:
-1.88%
abrysvo
positive
rsv
Orphan Drugs Market Projection: BCC Research Anticipates a Staggering $415.2 Billion Valuation by 2028, Reflecting Soaring Global Demand
Published:
2024-02-09
(Crawled : 10:00)
- prnewswire.com
ALPMF
|
News
|
$9.75
43.47%
200
|
Health Technology
|
-10.96%
|
O:
-0.91%
H:
3.88%
C:
3.88%
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
10.98%
|
O:
-2.6%
H:
2.26%
C:
1.44%
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
-7.92%
|
O:
-2.46%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.53
-1.11%
690K
|
Manufacturing
|
-11.18%
|
O:
4.66%
H:
0.0%
C:
-3.92%
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-4.75%
|
O:
-0.04%
H:
0.11%
C:
0.0%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-6.5%
|
O:
-0.37%
H:
0.21%
C:
0.05%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-3.74%
|
O:
0.33%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
0.4%
|
O:
1.11%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
10.41%
|
O:
-1.28%
H:
1.05%
C:
-0.72%
research
global
market
Global Vaginitis Therapeutics Market Size Projected to Reach USD 7.20 Billion By 2032, With 8.1% CAGR Growth: Polaris Market Research
Published:
2023-11-23
(Crawled : 15:30)
- prnewswire.com
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
reach
research
global
therapeutics
market
Oncology Drugs Market worth $520 billion by 2033 - Exclusive Report by We Market Research
Published:
2023-11-10
(Crawled : 15:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
9.35%
|
O:
0.1%
H:
0.0%
C:
-2.14%
ALPMY
|
News
|
$9.53
-1.11%
690K
|
Manufacturing
|
-19.1%
|
O:
-3.48%
H:
3.87%
C:
3.61%
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-11.52%
|
O:
0.24%
H:
0.22%
C:
-0.91%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-0.6%
|
O:
-1.24%
H:
0.0%
C:
0.0%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-2.52%
|
O:
0.4%
H:
0.18%
C:
0.0%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
21.62%
|
O:
0.44%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
9.42%
|
O:
-1.33%
H:
0.22%
C:
-0.11%
report
research
market
Anti-inflammatory Therapeutics Market Size to Hit US$ 149.5 billion by 2031 | Exclusive Study by Transparency Market Research
Published:
2023-10-30
(Crawled : 09:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
12.78%
|
O:
-4.67%
H:
4.9%
C:
4.9%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
7.64%
|
O:
2.76%
H:
0.0%
C:
0.0%
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-12.79%
|
O:
0.43%
H:
1.46%
C:
1.03%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
2.71%
|
O:
1.69%
H:
0.25%
C:
-0.07%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
0.66%
|
O:
-1.39%
H:
0.79%
C:
0.64%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
17.45%
|
O:
2.29%
H:
0.44%
C:
-0.23%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
22.0%
|
O:
2.87%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
3.34%
|
O:
-0.85%
H:
0.0%
C:
0.0%
research
therapeutics
study
market
Global Vulvovaginal Candidiasis Treatment Market Research Report 2023-2028 - Demand for Cost-effective Vulvovaginal Candidiasis Treatment Soars with Growing Geriatric Population
Published:
2023-10-04
(Crawled : 23:00)
- prnewswire.com
ALPMY
|
News
|
$9.53
-1.11%
690K
|
Manufacturing
|
-29.46%
|
O:
0.59%
H:
0.29%
C:
0.22%
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-21.16%
|
O:
0.42%
H:
0.99%
C:
0.06%
SCYX
|
$1.53
6.25%
5.88%
150K
|
Health Technology
|
-35.14%
|
O:
0.45%
H:
4.04%
C:
0.45%
CDTX
|
News
|
$0.5141
0.04%
0.04%
1.9M
|
Health Technology
|
-45.16%
|
O:
0.39%
H:
10.33%
C:
3.9%
report
treatment
candidiasis
research
global
growing
market
Global Hemophilia Research Analysis Report 2023: A $21.07 Billion Market by 2030 - Approval of Gene Therapies and Monoclonal Antibodies Fueling Growth
Published:
2023-08-16
(Crawled : 01:00)
- prnewswire.com
TAK
|
News
|
$13.38
0.15%
0.9%
1.7M
|
Health Technology
|
-12.05%
|
O:
-0.26%
H:
0.26%
C:
-0.46%
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-25.8%
|
O:
-0.71%
H:
1.45%
C:
0.97%
NVO
|
News
|
$128.64
2.7%
-0.07%
3.7M
|
Health Technology
|
35.34%
|
O:
-0.3%
H:
1.35%
C:
0.05%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-13.05%
|
O:
-1.33%
H:
0.0%
C:
0.0%
report
approval
research
global
growth
market
North America Kidney Transplant Research Report 2023
Published:
2023-08-08
(Crawled : 22:00)
- prnewswire.com
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
14.58%
|
O:
1.11%
H:
0.53%
C:
0.53%
ALPMY
|
News
|
$9.53
-1.11%
690K
|
Manufacturing
|
-36.51%
|
O:
3.93%
H:
0.0%
C:
-3.08%
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-26.32%
|
O:
-0.11%
H:
1.29%
C:
0.67%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-8.03%
|
O:
-0.07%
H:
0.73%
C:
0.36%
MDT
|
$81.29
0.89%
0.0%
5.2M
|
Health Technology
|
-4.0%
|
O:
-1.98%
H:
1.7%
C:
0.81%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-11.38%
|
O:
0.81%
H:
0.0%
C:
0.0%
america
report
kidney
research
Pfizer Announces Executive Leadership to Advance Oncology Research and Development Strategy
Published:
2023-07-27
(Crawled : 14:00)
- biospace.com/
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-29.43%
|
O:
-1.16%
H:
0.0%
C:
0.0%
research
Pyxis Oncology Announces Dosing of First Subject in Phase 1 Trial of PYX-201, a Novel ADC for Solid Tumors
Published:
2023-03-16
(Crawled : 12:20)
- biospace.com/
PYXS
|
$4.48
-1.1%
-1.12%
380K
|
Professional, Scientific, and T...
|
125.37%
|
O:
0.0%
H:
7.46%
C:
7.46%
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-34.81%
|
O:
-0.55%
H:
1.07%
C:
0.77%
pyx-201
tumors
trial
phase 1
Pfizer Invests $43 Billion to Battle Cancer
Published:
2023-03-13
(Crawled : 12:00)
- biospace.com/
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-33.33%
|
O:
-0.34%
H:
3.18%
C:
1.54%
SGEN
|
$228.74
0.1%
20M
|
Health Technology
|
32.52%
|
O:
15.14%
H:
2.07%
C:
-0.55%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-3.12%
|
O:
-0.81%
H:
0.0%
C:
0.0%
cancer
Optic Nerve Disorder Treatment Market to Reach USD 5.3 Billion, Globally, by 2031 at 4.5% CAGR: Allied Market Research
Published:
2023-02-27
(Crawled : 07:00)
- prnewswire.com
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-37.1%
|
O:
-0.74%
H:
0.7%
C:
-1.59%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
10.69%
|
O:
0.64%
H:
0.01%
C:
-0.72%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
9.94%
|
O:
0.36%
H:
0.97%
C:
0.67%
treatment
research
market
Pfizer’s Elranatamab Receives FDA and EMA Filing Acceptance
Published:
2023-02-22
(Crawled : 14:00)
- biospace.com/
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-38.5%
|
O:
0.05%
H:
0.39%
C:
-0.8%
fda
ema
Global Vaccines Market Research Report 2022-2027: A $200+ Billion Industry - Forecasts, Company Market Share and Expert Market Estimates for Vaccine Categories
Published:
2023-02-08
(Crawled : 16:00)
- prnewswire.com
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-39.76%
|
O:
-0.09%
H:
1.26%
C:
0.99%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-8.74%
|
O:
-0.06%
H:
0.77%
C:
0.19%
EBS
|
News
|
$2.29
6.02%
0.0%
860K
|
Health Technology
|
-84.68%
|
O:
-0.78%
H:
0.79%
C:
-5.29%
SNGX
|
$0.4012
-1.13%
-1.15%
450K
|
Health Technology
|
-93.93%
|
O:
-0.07%
H:
4.9%
C:
2.27%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-0.03%
|
O:
3.05%
H:
0.0%
C:
0.0%
NVAX
|
$4.205
3.32%
3.21%
3.6M
|
Health Technology
|
-62.63%
|
O:
0.0%
H:
1.74%
C:
-4.13%
INO
|
$10.34
3.19%
3.09%
240K
|
Health Technology
|
438.71%
|
O:
-1.61%
H:
2.73%
C:
-8.47%
BNTX
|
News
|
$88.53
0.59%
0.59%
360K
|
Health Technology
|
-38.07%
|
O:
-1.35%
H:
1.53%
C:
0.68%
research
global
report
vaccine
market
Vitamin D Market is expected to generate a revenue of USD 2.07 Billion by 2030, Globally, at 6.45% CAGR: Verified Market Research®
Published:
2023-01-25
(Crawled : 15:00)
- prnewswire.com
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-41.27%
|
O:
0.72%
H:
0.18%
C:
0.09%
research
expected
market
Acute Migraine Treatment Market Value to Exceed US$ 7.9 Billion by 2031, Reveals Transparency Market Research
Published:
2023-01-11
(Crawled : 12:00)
- prnewswire.com
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-44.86%
|
O:
0.17%
H:
0.08%
C:
-0.52%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
4.79%
|
O:
0.52%
H:
0.07%
C:
-0.48%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-14.87%
|
O:
0.23%
H:
0.09%
C:
-0.39%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
107.32%
|
O:
0.45%
H:
2.09%
C:
1.71%
treatment
research
migraine
market
Global Joint Pain Injections Market Forecast & Share Worth USD 10.75 Billion, By 2030 at 7.9% CAGR | Joint Pain Injections Industry Trends, Demand, Growth, Value, Analysis & Size Report by Zion Market Research
Published:
2023-01-02
(Crawled : 15:00)
- prnewswire.com
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
ANIK
|
$25.765
-0.71%
-0.72%
36K
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
research
global
report
market
HIV Clinical Trials Market Research Report by Phase, Study Design, Sponsor, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published:
2022-12-26
(Crawled : 13:20)
- prnewswire.com
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
Email alert
Add to watchlist
NVO
|
News
|
$128.64
2.7%
-0.07%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
Email alert
Add to watchlist
SYNH
|
$42.98
0.0%
7.4M
|
Health Services
|
Email alert
Add to watchlist
ICLR
|
News
|
$306.16
2.76%
2.68%
860K
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
Email alert
Add to watchlist
covid-19
trials
research
global
report
hiv
impact
study
market
Pfizer Announces FDA and EMA Acceptance of Etrasimod Regulatory Submissions for Ulcerative Colitis
Published:
2022-12-21
(Crawled : 13:00)
- biospace.com/
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-48.83%
|
O:
0.56%
H:
1.08%
C:
0.11%
fda
ema
ulcerative colitis
Anumana and Pfizer Partner to Enable Early Detection of Underdiagnosed Cardiovascular Disease
Published:
2022-12-15
(Crawled : 12:20)
- biospace.com/
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-51.8%
|
O:
-0.75%
H:
0.67%
C:
-0.85%
disease
cardiovascular
← Previous
1
2
3
Next →
Gainers vs Losers
78%
22%
Top 10 Gainers
MTTR
|
News
4
|
$4.6
164.37%
62.17%
28M
|
AGBA
|
$2.94
135.2%
57.48%
66M
|
Finance
EDBL
|
News
|
$6.46
71.81%
41.8%
2M
|
MTC
|
$2.25
44.23%
30.67%
6M
|
Technology Services
OPRT
|
News
|
$3.175
41.11%
29.13%
12M
|
Finance
SHIM
|
$3.05
35.56%
26.23%
1.1M
|
HKIT
|
$1.345
31.86%
24.16%
390K
|
Technology Services
ABVC
|
$1.36
30.77%
23.53%
7.4M
|
Wholesale Trade
OST
|
$0.512
28.0%
21.88%
290K
|
POET
|
$1.59
27.2%
21.38%
4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.